Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:

NCL Method GTA-6

By Stephan Stern, Timothy Potter

HepG2 Hepatocarcinoma Apoptosis Assay

Listed in Datasets | publication by group NCL Protocols

Version 2.0 - published on 09 Jul 2020 doi:10.17917/3F7T-M688 - cite this

Licensed under these terms


This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade.  The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.

Content List

Cite this work

Researchers should cite this work as follows:


Relation to series

The publication is part of the series below:


Powered by ...

NCL Protocols

NCL Protocols group image

When watching a publication, you will be notified when a new version is released.